Large Cap
Medical Instruments & Supplies
Stocks Ranked by
Market Capitalization
| # | Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|---|
| 1 |
1
Intuitive Surgical
ISRG
$131B
| $131B | $371.84 | 0.46% |
|
| 2 |
2
Becton Dickinson
BDX
$51.7B
| $51.7B | $189.78 | 0.5% |
|
| 3 |
3
Alcon
ALC
$35.5B
| $35.5B | $73.37 | 0.45% |
|
| 4 |
4
ResMed
RMD
$34.1B
| $34.1B | $236.59 | 1.78% |
|
| 5 |
MDLN
5
Medline Inc
MDLN
$31.3B
| $31.3B | $35.64 | 2.71% |
|
| 6 |
6
West Pharmaceutical
WST
$24.5B
| $24.5B | $348.48 | 1.37% |
|
| 7 |
7
Solventum
SOLV
$15.6B
| $15.6B | $91.61 | 0.39% |
|
| 8 |
8
Cooper Companies
COO
$14.2B
| $14.2B | $73.04 | 3.64% |
|
| 9 |
9
Baxter International
BAX
$13.6B
| $13.6B | $26.29 | 0.76% |
|
| 10 |
10
Align Technology
ALGN
$11.3B
| $11.3B | $159.61 | 0.02% |
|
| 11 |
11
Repligen
RGEN
$10.3B
| $10.3B | $181.69 | 0.04% |
|
Large Cap Medical Instruments & Supplies Stocks at a Glance
Medical instruments and supplies companies make the consumables and tools of daily care — syringes, catheters, surgical instruments, dental equipment, and eyewear. Recurring, procedure-driven demand makes the group defensive, with razor-and-blade consumable models supporting stable margins.
There are 11 large cap Medical Instruments & Supplies stocks — companies in the Medical Instruments & Supplies industry with a market cap between $10B and $200B — worth a combined $373B.
The largest by market cap are Intuitive Surgical (ISRG) at $131B, Becton Dickinson (BDX) at $51.7B and Alcon (ALC) at $35.5B.
Among institutional investors, Medline Inc (MDLN) drew the most net new fund positions in Q2 2026: 170 funds opened new positions, taking total fund holders up 92 (29%) quarter-over-quarter.
- Combined market cap: $373B across 11 stocks.
- Large Cap: market cap between $10B and $200B.
- Largest constituent: Intuitive Surgical (ISRG), $131B market cap.
- Most net new fund positions in Q2 2026: Medline Inc (MDLN), +92 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.